SETDB1 and colorectal carcinoma: Study showed that SETDB1 is upregulated and has a poor outcome in CRC, which is consistent with previous studies.[49] However, it is important to interpret this result cautiously, considering that other factors such as treatment approaches and patient comorbidities may also contribute to patient outcomes.